Library
On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.
Guidelines for the identification and management of substance use and substance use disorders in pregnancy
These WHO guidelines have been developed to provide evidence-based recommendations for identifying and managing substance use and substance use disorders in pregnancy.
These WHO guidelines have been developed to provide evidence-based recommendations for identifying and managing substance use and substance use disorders in pregnancy.
Financing drug policy in Europe in the wake of the economic recession
By examining public expenditure in the areas where most drug-related activities are provided, this report looks at how European austerity affected responses to the drugs problem.
By examining public expenditure in the areas where most drug-related activities are provided, this report looks at how European austerity affected responses to the drugs problem.
Alternatives to incarceration for drug-related crimes
This report examines alternatives to incarceration that have been used in different countries of the world for drug-related offenses.
This report examines alternatives to incarceration that have been used in different countries of the world for drug-related offenses.
Drug consumption rooms in Europe Models: Best practice and challenges
The increasing concern about the spread of HIV/AIDS, the significant increase of drug related deaths, and the growth of public drug scenes in a number of European cities push several EU states to promote harm reduction approaches in the 80´s.
The increasing concern about the spread of HIV/AIDS, the significant increase of drug related deaths, and the growth of public drug scenes in a number of European cities push several EU states to promote harm reduction approaches in the 80´s.
Confronting inadvertent stigma and pejorative language in addiction research
An editorial advocating for a "people-first language"; for a language that focuses on the medical nature of substance use disorders and treatment; promotes the recovery process; and avoids perpetuating negative stereotypes.
An editorial advocating for a "people-first language"; for a language that focuses on the medical nature of substance use disorders and treatment; promotes the recovery process; and avoids perpetuating negative stereotypes.
WHO: Community management of opioid overdose
WHO recommends that naloxone be made available to people likely to witness an opioid overdose, as well as training in the management of opioid overdose.
WHO recommends that naloxone be made available to people likely to witness an opioid overdose, as well as training in the management of opioid overdose.
Care when there is not cure
To ensure proper medical care for chronic and patients with terminal illness, access to palliative care and pain medicines is essential.
To ensure proper medical care for chronic and patients with terminal illness, access to palliative care and pain medicines is essential.
The link between amphetamine-type stimulants use and the transmission of blood-borne viruses in the Southeast Asian region
Amphetamine-type stimulant use is a major public health issue in the Southeast Asia region and swift action is needed to prevent the spread of HIV and other blood-borne viruses.
Amphetamine-type stimulant use is a major public health issue in the Southeast Asia region and swift action is needed to prevent the spread of HIV and other blood-borne viruses.
HIV in the United Kingdom: 2014 Report
An estimated 2,400 people who inject drugs (PWID) were living with HIV in the UK, of whom 9.9% (230) were undiagnosed.
An estimated 2,400 people who inject drugs (PWID) were living with HIV in the UK, of whom 9.9% (230) were undiagnosed.
Pregnancy and opioid use: Strategies for treatment
Illicit opioid consumption during pregnancy brings with it the risk of an increase in obstetric complications for the mother and a range of potential dangers for the child, both before and after birth. This paper reviews methadone, buprenorphine and slow-release oral morphine, used in a range of combinations.
Illicit opioid consumption during pregnancy brings with it the risk of an increase in obstetric complications for the mother and a range of potential dangers for the child, both before and after birth. This paper reviews methadone, buprenorphine and slow-release oral morphine, used in a range of combinations.
